CTOs on the Move

EIDAM DIAGNOSTICS CORPORATION

www.eidam.com

 
EIDAM DIAGNOSTICS CORPORATION is a Richmond, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.eidam.com
  • 11120 Horseshoe Way
    Richmond, BC CAN V7A 5H7
  • Phone: 604.207.9811

Executives

Name Title Contact Details

Similar Companies

ForTec Companies

ForTec Companies is a Streetsboro, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Shimadzu Medical Systems

Shimadzu Medical Systems is a Torrance, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dansereau Health Products

Dansereau Health Products is a Corona, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bovie Medical

Bovie Medical Corporation is a leading maker of medical devices and supplies as well as the developer of J-Plasma®, a patented new plasma-based surgical product for cutting and coagulation. J-Plasma® utilizes a helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery. Bovie Medical Corporation is also a leader in the manufacture of a range of electrosurgical products and technologies, marketed through both private labels and the Company`s own well-respected brands (Bovie®, Aaron®, IDS™ and ICON™) to distributors worldwide. The Company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers.

Seno Medical Instruments

Seno Medical Instruments, Inc. is a San Antonio, Texas-based medical imaging company committed to the development and commercialization of a new modality in cancer diagnosis: opto-acoustic imaging. Seno`s Imagio breast imaging system fuses opto-acoustic technology with ultrasound to generate functional and anatomical images of the breast. The opto-acoustic images provide a unique blood map in and around suspicious breast masses while the ultrasound provides a traditional anatomic image. Through the appearance or absence of the two hallmark indicators of cancer – angiogenesis and deoxygenation – Seno believes that the Imagio OA breast imaging system will be a more effective tool to help radiologists confirm or rule out malignancy than current diagnostic imaging modalities – without exposing patients to potentially harmful ionizing radiation (x-rays) or contrast agents.